Department of Nephrology, Tianjin First Central Hospital, Tianjin, China.
Key Laboratory of Critical Care Emergency Medicine of National Health Commission, Tianjin, China.
Blood Purif. 2023;52(5):437-445. doi: 10.1159/000528734. Epub 2023 Jan 19.
This study evaluated the incidence, clinical characteristics, and risk factors of kidney involvement in patients with the Omicron variant infection in the post-acute treatment phase in Tianjin, China.
Data were collected from 430 patients with Omicron variant infection in Tianjin, China. Demographics, comorbidities, laboratory blood tests, urinalysis, vaccination status, and COVID-19 clinical classification were assessed. Patients were grouped based on kidney involvement, and associated risk factors of kidney involvement were also investigated.
Asymptomatic, mild, ordinary, and severe patients with Omicron COVID-19 variant comprised 1.5%, 49.1%, 48.9%, and 0.5% of the sample population, respectively, without critical illness or death. The incidences of hematuria, proteinuria, and concurrent hematuria and proteinuria were 14.7%, 14.2%, and 5.1%, respectively. Patients with and without kidney involvement differed in age, body mass index (BMI), comorbidity, creatinine levels, estimated glomerular filtration rate, and C-reactive protein (CRP) levels. Age, hypertension, higher CRP levels, and higher BMI were linked with kidney involvement.
The majority of the patients suffered from mild or ordinary symptoms of Omicron COVID-19 infection. The primary kidney involvement was hematuria and proteinuria. Proteinuria was significantly associated with Omicron variant infection, and patients with hypertensive comorbidity, higher CRP, and higher creatinine levels were at increased risk of proteinuria after Omicron variant infection.
本研究评估了中国天津奥密克戎变异感染后急性治疗期患者肾脏受累的发生率、临床特征和危险因素。
收集了 430 例中国天津奥密克戎变异感染患者的数据。评估了人口统计学、合并症、实验室血液检查、尿液分析、疫苗接种状况和 COVID-19 临床分类。根据肾脏受累情况对患者进行分组,并探讨了肾脏受累的相关危险因素。
无症状、轻症、普通型和重型奥密克戎 COVID-19 变异患者分别占样本人群的 1.5%、49.1%、48.9%和 0.5%,无危重症或死亡病例。血尿、蛋白尿和血尿合并蛋白尿的发生率分别为 14.7%、14.2%和 5.1%。有肾脏受累和无肾脏受累的患者在年龄、体重指数(BMI)、合并症、肌酐水平、估算肾小球滤过率和 C 反应蛋白(CRP)水平方面存在差异。年龄、高血压、更高的 CRP 水平和更高的 BMI 与肾脏受累相关。
大多数患者患有轻度或普通的奥密克戎 COVID-19 感染症状。主要的肾脏受累表现为血尿和蛋白尿。蛋白尿与奥密克戎变异感染显著相关,合并高血压的患者、更高的 CRP 和更高的肌酐水平的患者在奥密克戎变异感染后蛋白尿的风险增加。